Safety, Tolerability, and Pharmacokinetics of IRL201104 in Healthy Volunteers

NCT05921591 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: IRL201104
DRUG: Placebo

Sponsor

Revolo Biotherapeutics